Subiaco-based biopharmaceutical company Phylogica Ltd has launched a share placement and share purchase plan to raise a total of $3.75 million to help fund its drug discovery projects.
Perth-based drug discovery company Phylogica Ltd has announced a research collaboration and licence agreement with global pharmaceutical group Johnson & Johnson's Australian research arm, Johnson & Johnson Research Pty Ltd.
Perth drug discovery company Phylogica has become Australia's top biotech stock this year, with its share price up by about 250 per cent over the past five months.
PERTH-BASED drug discovery company Phylogica has announced Canadian biotechnology firm, Axela Biosensors, will be testing its screening technology on Phylogica's large pool of Phylomer drug candidates
LOCAL biotechnology company Phylogica has announced a new discovery of proprietary compounds that protect brain cells under conditions that simulate stroke.
Local biotechnology company Phylogica has listed on the Australian Stock Exchange, closing at a premium of 37.5 per cent over the subscription price of 20 cents on its first day.
